Viatris Inc. – Material Contracts Watch

from 10-Q 2 pages February 16, 2024 Dear Corinne: On Behalf of Viatris Inc. (The “Company “), I Am Pleased to Confirm the Terms of Employment Offered by the Company in Connection With Your Role as Chief Commercial Officer of the Company Effective as of March 1, 2024, (The “Effective Date “)

from 10-K 2 pages Amendment to the Viatris Inc. 2020 Stock Incentive Plan

from 10-K 16 pages Separation Agreement and Release

from 10-K 13 pages Separation Agreement and Release

from 10-K 16 pages Retirement and Operating Consulting Agreement and Release

from 10-K 2 pages December 15, 2023 on Behalf of Viatris Inc. (The “Company”), I Am Pleased to Confirm the Terms of Employment Offered by the Company in Connection With Your Future Role as Chief Financial Officer of the Company

from 10-Q 15 pages Transition and Advisory Agreement and Release

from 10-Q 7 pages Viatris Inc. Performance-Based Restricted Stock Unit Award Agreement

from 8-K 13 pages Separation Agreement and Release

from 8-K 2 pages February 24, 2023 Scott A. Smith C/O Last Address on File With the Company Dear Scott: On Behalf of Viatris Inc. (The “Company”), I Am Pleased to Confirm the Terms of Employment Offered by the Company in Connection With Your Role as Chief Executive Officer of the Company Effective as of April 1, 2023 (The “Effective Date”). 1. Position. Your Position Shall Be Chief Executive Officer, and You Shall Devote Your Full Business Time and Attention to Such Position. You Shall Report to the Board of Directors (The “Board”) and You Shall Perform Such Duties as Requested by the Board. 2. Work Location. in the First Twelve (12) Months, It Is Anticipated That a Significant Portion of Your Working Time Will Be Spent at Company Offices in New York and/or Pittsburgh. You Will Also Be Required to Travel as Dictated by Business Needs. 3. Base Salary. Your Annual Base Salary Shall Be $1,400,000 (“Base Salary”), Payable on the Company’s Standard Payroll Dates and Subject to Deductions and Withholdings as Required by Applicable Law

from 10-Q 7 pages Viatris Inc. Director Restricted Stock Unit Award Agreement

from 10-Q 10 pages Viatris Inc. Performance-Based Restricted Stock Unit Award Agreement

from 10-Q 8 pages Viatris Inc. Restricted Stock Unit Award Agreement

from 10-K/A 5 pages December 3, 2020 Anthony Mauro C/O Mylan Inc. 1000 Mylan Boulevard Canonsburg, Pennsylvania 15317 Re: Retention Agreement Dear Mr. Mauro

from 10-K 13 pages Form of Indemnification Agreement

from 10-K 19 pages Recitals

from 10-K 5 pages December 3, 2020 Anthony Mauro C/O Mylan Inc. 1000 Mylan Boulevard Canonsburg, Pennsylvania 15317 Re: Retention Agreement Dear Mr. Mauro

from 10-K 5 pages December 3, 2020 Rajiv Malik C/O Mylan Inc. 1000 Mylan Boulevard Canonsburg, Pennsylvania 15317 Re: Retention Agreement Dear Mr. Malik

from 10-K 3 pages As You Know, Upjohn Inc. (“Upjohn”) and Mylan N.V. (“Mylan”) Consummated the Combination of Mylan and Upjohn Pursuant to the Business Combination Agreement Between Pfizer Inc., Upjohn, Mylan and the Other Parties Thereto to Create Viatris Inc. (“Viatris”), a New Champion for Global Health, on November 16, 2020 (The “Closing Date”). This Letter (The “Severance Letter”) Sets Forth Our Mutual Agreement Regarding Your Rights Upon a Termination of Employment From Viatris

from 10-K 2 pages July 29, 2019 Confidential Michael Goettler 235 East 42nd Street New York, Ny 10017 Re: Upjohn Deal Completion Bonus Upjohn Deal Completion Bonus